Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis

被引:17
作者
Fieren, MWJA
机构
[1] Department of Internal Medicine I, University Hospital ‘Dijkzigt’, Erasmus University Rotterdam, Rotterdam
关键词
peritoneal dialysis; continuous ambulatory; infection; macrophages; interleukin; 1; tumor necrosis factor; prostaglandin E(2); prostacyclin; nitric oxide;
D O I
10.1159/000170261
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proinflammatory cytokines interleukin-1 (IL-1 beta) and tumor necrosis factor-alpha (TNF alpha) are key mediators of the body's response to infection. Peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients isolated during peritonitis have an increased capacity to secrete IL-1 beta and TNF alpha. This peritoneal macrophage activation for Il-1 beta and TNF alpha release is a two-stage process. in contrast, peritonitis macrophages and infection-free macrophages stimulated in vitro with bacteria generate a decreased amount of the anti-inflammatory prostanoids. Exogenous and endogenous prostaglandin E(2) (PGE(2)) was found to inhibit the release of TNF alpha rather than IL-1 beta from peritoneal macrophages, indicating that the synthesis and secretion of these cytokines is distinctly regulated by PGE(2). In addition to macrophage products, acting in an autocrine fashion cytokine production and release may be regulated by secretory products of other cells in the peritoneal cavity including lymphocytes and mesothelial cells, which have the capability to produce various mediators. No evidence was found that the NO system is an important part of the antimicrobial arsenal of peritoneal macrophages.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 60 条
[1]  
Adams D O, 1992, INFLAMMATION BASIC P, P645
[2]   INFECTIOUS-INFLAMMATORY CHANGES IN CYCLIC-AMP LEVELS AND IN THEIR REGULATION BY PROSTAGLANDINS IN HUMAN PERITONEAL-MACROPHAGES [J].
ADOLFS, MJP ;
FIEREN, MWJA ;
BONTA, IL .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1985, 18 (02) :217-226
[3]   INFLAMMATION AMPLIFIES THE ANTITUMOR CYTOSTASIS BY HUMAN PERITONEAL-MACROPHAGES [J].
BENEFRAIM, S ;
TAK, C ;
FIEREN, MJWA ;
VANDENBEMD, GJCM ;
BONTA, IL .
MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1991, 8 (02) :87-94
[4]   THERAPEUTIC EFFECT OF ACTIVATED HUMAN MACROPHAGES ON A HUMAN TUMOR LINE GROWING IN NUDE-MICE [J].
BENEFRAIM, S ;
TAK, C ;
ROMIJN, JC ;
FIEREN, MJWA ;
BONTA, IL .
MEDICAL ONCOLOGY, 1994, 11 (01) :7-12
[5]   ACTIVITY OF HUMAN PERITONEAL-MACROPHAGES AGAINST A HUMAN TUMOR - ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA, PGE2 AND NITRITE, IN-VITRO STUDIES [J].
BENEFRAIM, S ;
TAK, C ;
FIEREN, MJWA ;
ROMIJN, JC ;
BECKMANN, I ;
BONTA, IL .
IMMUNOLOGY LETTERS, 1993, 37 (01) :27-33
[6]   CYCLIC-AMP LEVELS AND THEIR REGULATION BY PROSTAGLANDINS IN PERITONEAL-MACROPHAGES OF RATS AND HUMANS [J].
BONTA, IL ;
ADOLFS, MJP ;
FIEREN, MWJA .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1984, 6 (06) :547-555
[7]   INVOLVEMENT OF INFLAMMATORY MEDIATORS IN MACROPHAGE ANTITUMOR-ACTIVITY [J].
BONTA, IL ;
BENEFRAIM, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (06) :613-626
[8]   IMMUNOMODULATORY-ANTIINFLAMMATORY FUNCTIONS OF E-TYPE PROSTAGLANDINS - MINIREVIEW WITH EMPHASIS ON MACROPHAGE-MEDIATED EFFECTS [J].
BONTA, IL ;
PARNHAM, MJ .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1982, 4 (02) :103-109
[9]   TUMOR-NECROSIS-FACTOR IN INFLAMMATION - RELATION TO OTHER MEDIATORS AND TO MACROPHAGE ANTITUMOR DEFENSE [J].
BONTA, IL ;
BENEFRAIM, S ;
MOZES, T ;
FIEREN, MWJA .
PHARMACOLOGICAL RESEARCH, 1991, 24 (02) :115-130
[10]   INTERLEUKIN-6 AND INTERLEUKIN-8 IN DIALYSATE AND SERUM FROM PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
BRAUNER, A ;
HYLANDER, B ;
WRETLIND, B .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (03) :430-435